Informazione:
Errore:
ID
34587
Descrizione
Efficacy and Safety of the Fixed Dose Combination of Glimepiride+Metformin in Type 2 Diabetic Patients Inadequately Controlled; ODM derived from: https://clinicaltrials.gov/show/NCT01699932
collegamento
https://clinicaltrials.gov/show/NCT01699932
Keywords
versioni (1)
- 19/01/19 19/01/19 -
Titolare del copyright
see on clinicaltrials.gov
Caricato su
19 gennaio 2019
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Eligibility Type 2 Diabetes Mellitus NCT01699932
Eligibility Type 2 Diabetes Mellitus NCT01699932
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes Mellitus NCT01699932
- StudyEvent: Eligibility
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
ID.1
Item
patients with type 2 diabetes mellitus inadequately controlled despite a treatment with sulfonylurea (su) alone or metformin alone or a free combination of su and metformin prior to the study entry.
boolean
ID.2
Item
signed informed consent, obtained prior any study procedure
boolean
ID.3
Item
age < legal age of adulthood
boolean
ID.4
Item
hba1c < 7% or ≥ 11%
boolean
ID.5
Item
bmi > 35 kg/m2
boolean
ID.6
Item
treatment with a stable dose of maximally tolerated su alone or metformin alone or the free combination of su and metformin for less than 12 weeks prior to the screening visit.
boolean
ID.7
Item
patients who received any anti-diabetic drug other than su or metformin within 12 weeks prior to the screening visit.
boolean
ID.8
Item
diabetes other than type 2 diabetes (e.g. type 1 diabetes, diabetes secondary to pancreatic disorders, drug or chemical agent intake…)
boolean
ID.9
Item
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
boolean